Mariner
ESPR

Mariner’s Esperion Therapeutics ESPR Stock Holding History

Mariner’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$476K Sell
173,793
-104,868
-38% -$332K ﹤0.01% 2526
2025
Q4 		$1.03M Sell
278,661
-23,853
-8% -$77.1K ﹤0.01% 1934
2025
Q3 		$802K Buy
+302,514
New +$585K ﹤0.01% 2076
2023
Q4 		– Sell
-26,130
Closed -$25.6K – 3087
2023
Q3 		$25.6K Buy
26,130
+4,141
+19% +$5.99K ﹤0.01% 2830
2023
Q2 		$30.6K Buy
+21,989
New +$30.7K ﹤0.01% 2754
2023
Q1 		– Sell
-17,786
Closed -$111K – 2817
2022
Q4 		$111K Buy
17,786
+4,738
+36% +$33.9K ﹤0.01% 2498
2022
Q3 		$87K Buy
+13,048
New +$89.6K ﹤0.01% 2232

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return